Merck, a leading science and technology company, has announced that it has formed a strategic alliance with Baylor College of Medicine and its vaccine product development partnership (PDP), Texas Children’s Hospital Center for Vaccine Development (Texas Children’s CVD), to advance vaccine research and development for neglected and emerging infections.

The collaboration focuses on bringing vaccines through development to efficiently deliver them to societies in need. Merck’s experts in process development and formulation are working with Texas Children’s CVD scientists at Baylor to optimize the vaccine manufacturing process to increase vaccine stability and yield. Initially, these activities are targeting schistosomiasis, a deadly parasitic disease that affects millions of people a year in tropical and subtropical regions.

www.pharmabiz.com/NewsDetails.aspx?aid=103645&sid=2

About news

We take care of publishing the latest investment news and highlights for Feedback

Leave a Reply

Your email address will not be published. Required fields are marked *